Carmel Shachar, JD, MPH and Dorit Rubinstein Reiss, LLB, PhD
Legal approaches to preserving social stability, maintaining trust, supporting therapeutic research opportunities, or diminishing disease severity deserve ethical scrutiny.
AMA J Ethics. 2020; 22(1):E36-42. doi:
10.1001/amajethics.2020.36.
Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust.
AMA J Ethics. 2020; 22(1):E22-27. doi:
10.1001/amajethics.2020.22.
How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020; 22(1):E43-49. doi:
10.1001/amajethics.2020.43.
In this special edition of Ethics Talk, Dr Uché Blackstock joins us to discuss COVID-19 morbidity and mortality outcomes inequity by race and what needs to change now and postpandemic. Transcript available.
Professor john powell joins us for this special edition of Ethics Talk to discuss how a lens of “othering and belonging” can help us navigate our obligations to and relationships with each other, especially during this COVID-19 pandemic.
Pain is the most common reason patients seek health care. The AMA Pain Care Task Force suggests how clinicians can offer good pain care and become savvy about situating themselves in the health care system to do so.
AMA J Ethics. 2020; 22(8):E709-717. doi:
10.1001/amajethics.2020.709.